CATHERINE TISH: Open Payments
NPI 1366135410 · LOYSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,042 in 95 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $95 · 2025 $2,042
Food & beverage: $2,042
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $364 |
| AstraZeneca Pharmaceuticals LP | 8 | $320 |
| Phathom Pharmaceuticals, Inc. | 10 | $259 |
| Novo Nordisk Inc | 13 | $218 |
| GlaxoSmithKline, LLC. | 9 | $153 |
| Lilly USA, LLC | 12 | $146 |
| Sumitomo Pharma America, Inc. | 3 | $115 |
| Exact Sciences Corporation | 4 | $85 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $79 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $71 |
Products named: VOQUEZNA, VRAYLAR, AIRSUPRA, QULIPTA, FARXIGA, Wegovy, GEMTESA, MOUNJARO.
Industry payments across PA — which companies pay providers there.
